Page last updated: 2024-08-18

isomethyleugenol and Myelodysplastic Syndromes

isomethyleugenol has been researched along with Myelodysplastic Syndromes in 38 studies

Research

Studies (38)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (13.16)	18.2507
2000's	8 (21.05)	29.6817
2010's	18 (47.37)	24.3611
2020's	7 (18.42)	2.80

Authors

Authors	Studies
Diamantopoulos, PT; Dimou, M; Dryllis, G; Galanopoulos, A; Giannakopoulou, N; Giannopoulos, A; Hatzidavid, S; Kontandreopoulou, CN; Kotsianidis, I; Loupis, T; Panayiotidis, P; Pappa, V; Solomou, E; Symeonidis, A; Viniou, NA; Zoi, K	1
Hisasue, M; Neo, S; Tanaka, M	1
Jutzi, JS; Pahl, HL; Staehle, HF	1
Abdelhay, E; da Costa, ES; da Silva, BF; de Souza Fernandez, C; de Souza Fernandez, T; Lima, SCS; Lovatel, VL; Rodrigues, EF	1
Ades, L; Balabanian, K; Bisio, V; Boy, M; Caignard, A; Clappier, E; Dulphy, N; Espeli, M; Fain, O; Fenaux, P; Gagne, K; Guidez, F; Henry, G; Kim, R; Larcher, L; Lereclus, E; Mekinian, A; Retiere, C; Rodrigues-Lima, F; Schell, B; Sebert, M; Toubert, A; Villemonteix, J; Zhao, LP	1
Asou, N; Benoukraf, T; Matsumura, T; Matsuoka, M; Muddineni, SSNA; Nakamura-Ishizu, A; Okuda, T; Osato, M; Sian, S; Suda, T; Tan, DQ; Tirado-Magallanes, R; Tokunaga, K; Wang, CQ	1
Aluri, S; Bhatia, R; Cable, L; Chen, Y; Deng, H; Guo, H; Han, X; Iancu-Rubin, C; Jiang, M; Jin, J; Jin, S; Klug, CA; Krause, DS; Liu, J; Liu, SM; Luo, M; Nimer, SD; Qu, CK; Senevirathne, C; Shen, Y; Su, H; Sun, CW; Tran, NT; Verma, A; Xavier-Ferrucio, J; Xiang, J; Zhang, T; Zhao, Q; Zhao, X; Zheng, YG; Zhu, Y	1
Fujino, T; Goyama, S; Horikawa, S; Imoto, S; Inaba, T; Inoue, D; Kanai, A; Kawabata, KC; Kitamura, T; Kozuka-Hata, H; Li, Z; Matsui, H; Miyano, S; Nagase, R; Oyama, M; Saika, M; Sheridan, P; Xu, M; Yamaguchi, R; Yang, FC; Yokoyama, A; Zhang, YZ	1
Bao, N; Bueso-Ramos, CE; Class, C; Colla, S; Do, KA; Ganan-Gomez, I; Garcia-Manero, G; Jiang, S; Khoury, J; Lin, K; Lu, Y; Starczynowski, DT; Wei, Y; Yang, H; Zheng, H	1
Cai, YL; Zhang, JL; Zhu, XF	1
Platzbecker, U	1
Li, N; Ye, F	1
Anastasi, J; Cheng, JX; Grimley, E; Kleinbrink, EL; Knibbs, R; Shen, QJ; Vardiman, JW; Watanabe, K	1
Cocco, L; Duprez, E; Ford, KG; Maciejewski, JP; Melnick, A; Mufti, G; Nervi, C; Santini, V	1
Abdel-Wahab, O; Aburatani, H; Enomoto, Y; Harada, H; Harada, Y; Heuser, M; Inoue, D; Isobe, M; Izawa, K; Kagiyama, Y; Kawabata, KC; Kimura, H; Kitamura, T; Kitaura, J; Levine, RL; Maehara, A; Nakahara, F; Nishimura, K; Ochiya, T; Oki, T; Thol, F; Togami, K; Tsuchiya, A; Uchida, T	1
Byon, J; Deeg, HJ; Holman, ZJ; Jiang, PY; Karoopongse, E; Marcondes, AM; Ramakrishnan, A; Yeung, C; Yu, Q	1
Gao, L; Kang, HY; Li, MY; Wang, CB; Wang, LL; Wang, W; Wang, XR; Yu, L	1
DeZern, AE	1
Padron, E	1
Chen, XP; Jing, Y; Li, YH; Yu, L	1
Abboud, CN; Augustin, K; Cashen, AF; Dipersio, JF; Kreisel, F; Martin, MG; Procknow, E; Stockerl-Goldstein, K; Uy, GL; Vij, R; Walgren, RA; Westervelt, P	1
Malcovati, L	1
Frame, D	1
Issa, JP	1
Cattaneo, F; Dickstein, J; Fazzina, R; Laricchia-Robbio, L; Nucifora, G; Premanand, K; Senyuk, V; Xu, P	1
Elf, S; Hsieh, JJ; Huang, G; Lee, J; Liu, Y; Menendez, S; Nimer, SD; Osato, M; Sashida, G; Tenen, DG; Wang, L; Xu, H; Yan, X; Yang, Y; Zhang, P; Zhang, Y; Zhao, X	1
Gañán-Gómez, I; Garcia-Manero, G; McCay, SL; Salazar-Dimicoli, S; Wei, Y	1
Akria, L; Arad, A; Aviv, A; Braester, A; Dally, N; Filanovsky, K; Gafter-Gvili, A; Gatt, ME; Hellmann, I; Herishanu, Y; Herzog-Tzarfati, K; Leiba, R; Merkel, D; Mittelman, M; Nagler, A; Nemets, A; Ofran, Y; Ronson, A; Rouvio, O; Silbershatz, I; Tadmor, T; Vidal, L; Yeganeh, S	1
Di Mario, A; Guidi, F; Hohaus, S; Leone, G; Pagano, L; Scardocci, A; Voso, MT; Zini, G	1
Bench, AJ; Delabesse, E; Deloukas, P; Fourouclas, N; Green, AR; Hunt, AR; Huntly, BJ; Li, J	1
Ammerpohl, O; Bohle, RM; Bojesen, SE; Borkhardt, A; Fuchs, U; Haas, OA; Mettal, H; Weinhäusl, A	1
Chen, CY; Chen, YC; Chou, WC; Huang, SY; Ko, BS; Shen, MC; Tang, JL; Tien, HF; Tsay, W; Wang, CH; Wu, SJ; Yao, M; Yeh, YC	1
Galili, N; Raza, A; Raza, FZ	1
Dhodapkar, M; Grill, J; Lust, JA	1
Anttila, P; Heiskanen, M; Ihalainen, J; Juvonen, E; Palotie, A; Salo, A	1
Hotta, T; Ichikawa, A; Ito, T; Kagami, Y; Ohashi, H; Saito, H	1
Karasawa, M; Morita, K; Omine, M; Tsukamoto, N	1
Solberg, LA; Tefferi, A; Thibodeau, SN	1

Reviews

10 review(s) available for isomethyleugenol and Myelodysplastic Syndromes

Article	Year
The Cross Marks the Spot: The Emerging Role of JmjC Domain-Containing Proteins in Myeloid Malignancies. Biomolecules, 2021, 12-20, Volume: 11, Issue:12 Topics: Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Methylation; Myelodysplastic Syndromes; Myeloproliferative Disorders	2021
[Advances in the treatment of juvenile myelomonocytic leukemia]. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2018, Volume: 20, Issue:11 Topics: Child; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelomonocytic, Juvenile; Methylation; Myelodysplastic Syndromes; Signal Transduction	2018
Treatment of MDS. Blood, 2019, 03-07, Volume: 133, Issue:10 Topics: Disease Progression; Erythropoiesis; Hematology; Hematopoietic Stem Cell Transplantation; Humans; Intercellular Signaling Peptides and Proteins; Iron Chelating Agents; Lenalidomide; Methylation; Myelodysplastic Syndromes; Prognosis; Risk; Severity of Illness Index; Translational Research, Biomedical; Transplantation, Homologous	2019
Role of p15(INK4B) Methylation in Patients With Myelodysplastic Syndromes: A Systematic Meta-Analysis. Clinical lymphoma, myeloma & leukemia, 2019, Volume: 19, Issue:6 Topics: Case-Control Studies; Cyclin-Dependent Kinase Inhibitor p15; Disease Susceptibility; Epigenesis, Genetic; Humans; Male; Methylation; Myelodysplastic Syndromes; Odds Ratio; Publication Bias	2019
Epigenetics in focus: pathogenesis of myelodysplastic syndromes and the role of hypomethylating agents. Critical reviews in oncology/hematology, 2013, Volume: 88, Issue:2 Topics: Chromosome Aberrations; DNA Methylation; Epigenesis, Genetic; Epigenomics; Histone Deacetylase Inhibitors; Histones; Humans; Leukemia, Myeloid; Methylation; Myelodysplastic Syndromes	2013
Surveying the landscape of MDS/MPN research: overlap among the overlap syndromes? Hematology. American Society of Hematology. Education Program, 2015, Volume: 2015 Topics: Animals; Bone Marrow Neoplasms; Clinical Trials as Topic; Genome, Human; Genomics; Hematology; Humans; Medical Oncology; Methylation; Mice; Mutation; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases; Phenotype; Prognosis; Translational Research, Biomedical; World Health Organization	2015
[Markers for Predicting Response to Hypomethylating Agents in MDS and AML Patients]. Zhongguo shi yan xue ye xue za zhi, 2015, Volume: 23, Issue:6 Topics: Biomarkers, Tumor; Bone Marrow; Humans; Leukemia, Myeloid, Acute; Methylation; Myelodysplastic Syndromes	2015
Red blood cell transfusion therapy and iron chelation in patients with myelodysplastic syndromes. Clinical lymphoma & myeloma, 2009, Volume: 9 Suppl 3 Topics: beta-Thalassemia; Deferiprone; Disease Progression; DNA Methylation; Erythrocyte Transfusion; Erythrocytes; Ferritins; Humans; Immunosuppressive Agents; Iron Chelating Agents; Iron Overload; Methylation; Myelodysplastic Syndromes; Pyridones; Risk; Treatment Outcome	2009
Epigenetic changes in the myelodysplastic syndrome. Hematology/oncology clinics of North America, 2010, Volume: 24, Issue:2 Topics: Acetylation; Acute Disease; Azacitidine; Cell Transformation, Neoplastic; Decitabine; DNA Methylation; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Leukemia, Myeloid; Methylation; Myelodysplastic Syndromes; Neoplasms; Protein Processing, Post-Translational	2010
Histone methylation in myelodysplastic syndromes. Epigenomics, 2011, Volume: 3, Issue:2 Topics: Drug Delivery Systems; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histones; Humans; Methylation; Myelodysplastic Syndromes	2011

Trials

1 trial(s) available for isomethyleugenol and Myelodysplastic Syndromes

Article	Year
A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes. American journal of hematology, 2009, Volume: 84, Issue:9 Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Humans; Injections; Methylation; Middle Aged; Myelodysplastic Syndromes; Remission Induction; Risk Assessment; Survival Analysis	2009

Other Studies

27 other study(ies) available for isomethyleugenol and Myelodysplastic Syndromes

Article	Year
Bone marrow ribonucleotide reductase mRNA levels and methylation status as prognostic factors in patients with myelodysplastic syndrome treated with 5-Azacytidine. Leukemia & lymphoma, 2022, Volume: 63, Issue:3 Topics: Azacitidine; Bone Marrow; Humans; Methylation; Myelodysplastic Syndromes; Prognosis; Ribonucleoside Diphosphate Reductase; Ribonucleotide Reductases; RNA, Messenger	2022
A cat with myelodysplastic syndrome by administration of the methylation inhibitor Azacytidine. The Journal of veterinary medical science, 2022, Jan-24, Volume: 84, Issue:1 Topics: Anemia; Animals; Azacitidine; Cat Diseases; Cats; Female; Leukopenia; Methylation; Myelodysplastic Syndromes	2022
Global methylation status of LINE-1 in pediatric myelodysplastic syndrome: a predictive biomarker of prognosis? Leukemia & lymphoma, 2022, Volume: 63, Issue:14 Topics: Biomarkers; Child; DNA Methylation; Humans; Methylation; Myelodysplastic Syndromes; Prognosis	2022
Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation. Nature communications, 2023, 02-03, Volume: 14, Issue:1 Topics: Azacitidine; Dioxygenases; DNA-Binding Proteins; Humans; Killer Cells, Natural; Methylation; Mutation; Myelodysplastic Syndromes; Receptors, KIR	2023
Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia. Blood, 2020, 10-22, Volume: 136, Issue:17 Topics: Animals; Apoptosis; Cell Survival; Core Binding Factor Alpha 2 Subunit; Family; Female; Genetic Predisposition to Disease; Genotype; Hematopoietic Stem Cells; Humans; Leukemia; Leukemia, Myeloid, Acute; Male; Methylation; Methyltransferases; Mice; Mice, Inbred C57BL; Mice, Transgenic; Middle Aged; Mutation, Missense; Myelodysplastic Syndromes; Pedigree; Protein Processing, Post-Translational	2020
Methylation of dual-specificity phosphatase 4 controls cell differentiation. Cell reports, 2021, 07-27, Volume: 36, Issue:4 Topics: Adult; Animals; Arginine; Cell Differentiation; Cell Line; Child; Dual-Specificity Phosphatases; Enzyme Stability; Female; HEK293 Cells; Humans; Male; MAP Kinase Signaling System; Megakaryocytes; Methylation; Mice, Inbred C57BL; Middle Aged; Mitogen-Activated Protein Kinase Phosphatases; Myelodysplastic Syndromes; p38 Mitogen-Activated Protein Kinases; Polyubiquitin; Protein-Arginine N-Methyltransferases; Proteolysis; Repressor Proteins; Ubiquitination; Young Adult	2021
A novel ASXL1-OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignancies. Leukemia, 2018, Volume: 32, Issue:6 Topics: Animals; Cell Differentiation; Female; HEK293 Cells; Histones; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Methylation; Mice; Mice, Inbred C57BL; Myelodysplastic Syndromes; N-Acetylglucosaminyltransferases; Protein Stability; Repressor Proteins; Tumor Suppressor Proteins	2018
KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice. Blood advances, 2018, 10-09, Volume: 2, Issue:19 Topics: Animals; Bone Marrow; Chromatin; Flow Cytometry; Gene Expression; Gene Expression Profiling; Hematopoiesis; Hematopoietic Stem Cells; Histones; Humans; Immunity, Innate; Immunomodulation; Jumonji Domain-Containing Histone Demethylases; Methylation; Mice; Mice, Knockout; Mice, Transgenic; Myelodysplastic Syndromes; Phenotype; Signal Transduction	2018
Genome-wide profiling reveals epigenetic inactivation of the PU.1 pathway by histone H3 lysine 27 trimethylation in cytogenetically normal myelodysplastic syndrome. Leukemia, 2013, Volume: 27, Issue:6 Topics: Aged; Aged, 80 and over; Case-Control Studies; Chromatin Immunoprecipitation; Epigenesis, Genetic; Female; Flow Cytometry; Genome, Human; Histones; Humans; Male; Methylation; Middle Aged; Myelodysplastic Syndromes; Proto-Oncogene Proteins; Real-Time Polymerase Chain Reaction; Trans-Activators	2013
Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations. The Journal of clinical investigation, 2013, Volume: 123, Issue:11 Topics: Animals; Cell Line; Disease Models, Animal; Histones; Homeodomain Proteins; Humans; Lectins, C-Type; Methylation; Mice; Mice, Inbred C57BL; MicroRNAs; Mutant Proteins; Mutation; Myelodysplastic Syndromes; Myelopoiesis; Peptide Fragments; Receptors, Cell Surface; Repressor Proteins	2013
The KDM2B- let-7b -EZH2 axis in myelodysplastic syndromes as a target for combined epigenetic therapy. PloS one, 2014, Volume: 9, Issue:9 Topics: Azacitidine; Bone Marrow Cells; Cell Line, Tumor; Cluster Analysis; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; F-Box Proteins; Gene Expression; Gene Expression Profiling; Gene Knockdown Techniques; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Methylation; MicroRNAs; Molecular Targeted Therapy; Myelodysplastic Syndromes; Polycomb Repressive Complex 2	2014
[Clinical Implications on ZO-1 Gene Methylation in Myelodysplastic Syndrome Progression]. Zhongguo shi yan xue ye xue za zhi, 2015, Volume: 23, Issue:3 Topics: Bone Marrow; Disease Progression; DNA Methylation; Humans; Leukemia, Myeloid, Acute; Methylation; Myelodysplastic Syndromes; Polymerase Chain Reaction; Zonula Occludens-1 Protein	2015
Nine years without a new FDA-approved therapy for MDS: how can we break through the impasse? Hematology. American Society of Hematology. Education Program, 2015, Volume: 2015 Topics: Algorithms; Azacitidine; Clinical Trials as Topic; Decitabine; Drug Approval; Drug Industry; Humans; Karyotyping; Lenalidomide; Methylation; Mutation; Myelodysplastic Syndromes; Prognosis; Risk Assessment; Thalidomide; United States; United States Food and Drug Administration	2015
Alternative dosing schedules for methylation inhibitors in MDS treatment. Managed care (Langhorne, Pa.), 2009, Volume: 18, Issue:11 Suppl 9 Topics: Antimetabolites, Antineoplastic; Azacitidine; Decitabine; Drug Administration Schedule; Humans; Methylation; Myelodysplastic Syndromes	2009
Methylation and silencing of miRNA-124 by EVI1 and self-renewal exhaustion of hematopoietic stem cells in murine myelodysplastic syndrome. Proceedings of the National Academy of Sciences of the United States of America, 2010, May-25, Volume: 107, Issue:21 Topics: Animals; Bone Marrow Transplantation; Cell Differentiation; Cell Proliferation; Cells, Cultured; CpG Islands; DNA Replication; DNA-Binding Proteins; Gene Expression Regulation; Hematopoietic Stem Cells; MDS1 and EVI1 Complex Locus Protein; Methylation; Mice; MicroRNAs; Molecular Sequence Data; Mutation; Myelodysplastic Syndromes; Promoter Regions, Genetic; Proto-Oncogenes; RNA Interference; Transcription Factors	2010
The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations. Blood, 2011, Dec-15, Volume: 118, Issue:25 Topics: Acute Disease; Blotting, Western; Cell Line; Cell Line, Tumor; Chromatin Immunoprecipitation; Core Binding Factor Alpha 2 Subunit; Core Binding Factor beta Subunit; Gene Expression; HEK293 Cells; Histone-Lysine N-Methyltransferase; Histones; Humans; Leukemia, Myeloid; Lysine; Methylation; Mutation; Myelodysplastic Syndromes; Myeloid-Lymphoid Leukemia Protein; Protein Binding; Proto-Oncogene Proteins; Regulatory Sequences, Nucleic Acid; Reverse Transcriptase Polymerase Chain Reaction; Trans-Activators	2011
Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter study. American journal of hematology, 2013, Volume: 88, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Azacitidine; Chromosome Aberrations; Disease Susceptibility; Female; Humans; Incidence; Infections; Israel; Leukemia, Myeloid, Acute; Male; Methylation; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Retrospective Studies; Risk Factors; Severity of Illness Index; Thrombocytopenia	2013
Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes. Blood, 2004, Jan-15, Volume: 103, Issue:2 Topics: Aged; Apoptosis; Apoptosis Regulatory Proteins; Bone Marrow Cells; Calcium-Calmodulin-Dependent Protein Kinases; Cell Transformation, Neoplastic; Death-Associated Protein Kinases; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Leukemia, Myeloid, Acute; Male; Methylation; Middle Aged; Myelodysplastic Syndromes; Polymerase Chain Reaction	2004
Characterization of the imprinted polycomb gene L3MBTL, a candidate 20q tumour suppressor gene, in patients with myeloid malignancies. British journal of haematology, 2004, Volume: 127, Issue:5 Topics: Alternative Splicing; Bone Marrow Diseases; Case-Control Studies; Chromosomal Proteins, Non-Histone; Chromosome Deletion; CpG Islands; DNA Mutational Analysis; Gene Expression; Genes, Tumor Suppressor; Humans; Methylation; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasm Proteins; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Sequence Alignment; Tumor Suppressor Proteins	2004
Characterisation of the GRAF gene promoter and its methylation in patients with acute myeloid leukaemia and myelodysplastic syndrome. British journal of cancer, 2006, Jan-30, Volume: 94, Issue:2 Topics: Acute Disease; Base Sequence; Child; GTPase-Activating Proteins; Humans; K562 Cells; Leukemia, Myeloid; Methylation; Molecular Sequence Data; Myelodysplastic Syndromes; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction	2006
Clinical implications of SOCS1 methylation in myelodysplastic syndrome. British journal of haematology, 2006, Volume: 135, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Chromosome Aberrations; Disease Progression; Female; Genes, ras; Humans; Karyotyping; Leukemia; Male; Methylation; Middle Aged; Mutation; Myelodysplastic Syndromes; Polymerase Chain Reaction; Prognosis; Risk Factors; Suppressor of Cytokine Signaling 1 Protein; Suppressor of Cytokine Signaling Proteins	2006
Low-dose decitabine and high-risk MDS. Blood, 2006, Dec-15, Volume: 108, Issue:13 Topics: Antimetabolites, Antineoplastic; Azacitidine; Decitabine; Female; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methylation; Myelodysplastic Syndromes; Neoplasm Proteins; Protein Processing, Post-Translational; Randomized Controlled Trials as Topic; Remission Induction; Risk Factors	2006
Abnormal regional hypermethylation of the calcitonin gene in myelodysplastic syndromes. Leukemia research, 1995, Volume: 19, Issue:10 Topics: Aged; Base Sequence; Blotting, Southern; Calcitonin; Humans; Leukemia, Myeloid, Acute; Methylation; Middle Aged; Molecular Sequence Data; Myelodysplastic Syndromes; Polymerase Chain Reaction; Survival Rate	1995
Idiopathic macrocytic anaemia in the aged: molecular and cytogenetic findings. British journal of haematology, 1995, Volume: 90, Issue:4 Topics: Aged; Aged, 80 and over; Anemia, Macrocytic; Calcitonin; Chromosome Aberrations; Chromosomes, Human, Pair 11; DNA; Female; Hematopoietic Stem Cells; Humans; Karyotyping; Male; Methylation; Myelodysplastic Syndromes; Point Mutation	1995
Recovery of polyclonal hematopoiesis in patients with myelodysplastic syndromes following successful chemotherapy. Leukemia, 1994, Volume: 8, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Female; Hematopoiesis; Humans; Methotrexate; Methylation; Middle Aged; Myelodysplastic Syndromes; Polymorphism, Restriction Fragment Length; Remission Induction	1994
Methylation status of c-myc oncogene in leukemic cells: hypomethylation in acute leukemia derived from myelodysplastic syndromes. Experimental hematology, 1992, Volume: 20, Issue:9 Topics: Acute Disease; Base Sequence; Blotting, Southern; DNA, Neoplasm; Genes, myc; Humans; Leukemia, Myeloid; Methylation; Myelodysplastic Syndromes; Proto-Oncogene Mas; Proto-Oncogene Proteins c-myc	1992
Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. Blood, 1990, May-01, Volume: 75, Issue:9 Topics: Bone Marrow; Deoxyribonuclease BamHI; Deoxyribonucleases, Type II Site-Specific; DNA; Female; Genetic Carrier Screening; Humans; Hypoxanthine Phosphoribosyltransferase; Karyotyping; Methylation; Myelodysplastic Syndromes; Phosphoglycerate Kinase; Polymorphism, Restriction Fragment Length; X Chromosome	1990